Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001571049-17-002838
Filing Date
2017-03-24
Accepted
2017-03-24 17:00:37
Documents
2
Period of Report
2017-03-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT t1700866_x1.html 3  
1 OWNERSHIP DOCUMENT t1700866_x1.xml 3 1626
2 EXHIBIT 24.1 t1700866_ex24-1.htm EX-24.1 7161
  Complete submission text file 0001571049-17-002838.txt   10381
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address GLENPOINTE CENTRE EAST, 3RD FL 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666
Business Address
Escudero Lisa Ann (Reporting) CIK: 0001701415 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36410 | Film No.: 17713370